Ann: USA Medicare Update, page-39

The industry seems very happy with this LCD. A drastic and incredibly positive shift in the position of the MACs, and a huge derisking and boost in confidence in the longer term revenue outlook for EYE. Reimbursement is no longer the major risk it used to be, it’s now a minor one at best (although I can’t see how the MACs go back now). This is why SGHT rallied 25% last week (and why I’m hoping we will catch up this week!).

Not to mention it reflects the support within the industry for this procedure, as well as the power the industry has to make changes to the regulatory framework that are beneficial to them. I’d be expect an even more favourable LCD outcome after negotiations take place.